Bristol-Myers says it inflated sales
Article Abstract:
Bristol-Myers Squibb Co. admitted that it inflated its sales figures during the 1999 to 2002 period. The company said that it inflated figures by up to $2.75 billion (2.5 billion euros) based on "inappropriate" accounting.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Shire sales increase amid Adderall growth
Article Abstract:
Shire Pharmaceuticals Group PLC posted over $1 billion (926,700) in sales for the 2002 year. The firm posted $852 million in sales in 2001. Shire was helped by the growth of its Adderall hyperactivity drug.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Serono's net misses target, but sales, outlook are solid
Article Abstract:
Serono S.A. posted lower than expected 2002 fourth quarter net profits of $81.6 million (75.9 million euros). However, the company continued to be positive about its 2003 forecasts.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic: